The company has significantly improved its course of an novel treatment for ATTR-CM, employing the compound. Preliminary trial results suggests promising improvements for those diagnosed by this serious illness. The https://bridgebio406861.blogolenta.com/39198266/company-advances-attr-cm-therapy-using-attruby